| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.881 | 0.003 | 0.881 | 5 Hydroxytryptamine 1 agonist | 0.793 0.003 DBMET01793 0.848 0.003 DBMET01792 0.814 0.003 DBMET03120 0.782 0.003 DBMET03121 | ||
| 0.876 | 0.001 | 0.877 | 5 Hydroxytryptamine 1B agonist | 0.787 0.002 DBMET01793 0.877 0.001 DBMET01792 0.827 0.001 DBMET03120 0.787 0.002 DBMET03121 | DBMET01792 | |
| 0.868 | 0.001 | 0.868 | 5 Hydroxytryptamine 1D antagonist | 0.416 0.004 DBMET01793 0.767 0.002 DBMET01792 0.332 0.004 DBMET03120 0.214 0.006 DBMET03121 | ||
| 0.865 | 0.001 | 0.865 | 5 Hydroxytryptamine 1D agonist | 0.422 0.002 DBMET01793 0.767 0.001 DBMET01792 0.427 0.002 DBMET03120 0.264 0.002 DBMET03121 | ||
| 0.816 | 0.002 | 0.816 | 5 Hydroxytryptamine 1B antagonist | 0.32 0.004 DBMET01793 0.739 0.002 DBMET01792 0.311 0.005 DBMET03120 0.178 0.01 DBMET03121 | ||
| 0.798 | 0.003 | 0.798 | 5 Hydroxytryptamine agonist | 0.627 0.004 DBMET01793 0.763 0.004 DBMET01792 0.669 0.004 DBMET03120 0.605 0.004 DBMET03121 | ||
| 0.619 | 0.004 | 0.619 | 5 Hydroxytryptamine 1 antagonist | 0.132 0.027 DBMET01793 0.457 0.005 DBMET01792 0.13 0.027 DBMET03120 | ||
| 0.556 | 0.004 | 0.556 | 5 Hydroxytryptamine 1F antagonist | 0.206 0.01 DBMET01793 0.415 0.005 DBMET01792 0.186 0.011 DBMET03120 0.166 0.014 DBMET03121 | ||
| 0.557 | 0.005 | 0.557 | 5 Hydroxytryptamine antagonist | 0.102 0.077 DBMET01793 0.424 0.01 DBMET01792 0.124 0.063 DBMET03120 | ||
| 0.505 | 0.027 | 0.609 | 5 Hydroxytryptamine release stimulant | 0.321 0.064 DBMET01793 0.609 0.014 DBMET01792 0.434 0.039 DBMET03120 0.405 0.045 DBMET03121 | DBMET01792 | |
| 0.467 | 0.042 | 0.574 | Calcium channel L-type activator | 0.458 0.047 DBMET01793 0.574 0.009 DBMET01792 0.492 0.031 DBMET03120 0.491 0.031 DBMET03121 | DBMET01792 | |
| 0.451 | 0.03 | 0.451 | Spasmolytic | 0.358 0.05 DBMET01792 0.276 0.08 DBMET03120 0.221 0.105 DBMET03121 | ||
| 0.417 | 0.019 | 0.43 | Insulysin inhibitor | 0.334 0.041 DBMET01793 0.42 0.019 DBMET01792 0.38 0.026 DBMET03120 0.43 0.018 DBMET03121 | DBMET03121 | |
| 0.393 | 0.002 | 0.393 | 5 Hydroxytryptamine 3E antagonist | 0.26 0.012 DBMET01793 0.359 0.003 DBMET01792 0.236 0.023 DBMET03120 0.207 0.052 DBMET03121 | ||
| 0.401 | 0.022 | 0.401 | Psychostimulant | 0.374 0.027 DBMET01792 0.18 0.093 DBMET03121 | ||
| 0.442 | 0.068 | 0.601 | Analgesic | 0.601 0.027 DBMET01793 0.515 0.045 DBMET01792 0.371 0.098 DBMET03120 0.395 0.087 DBMET03121 | DBMET01793 | |
| 0.371 | 0.006 | 0.371 | 5 Hydroxytryptamine 1A antagonist | 0.065 0.049 DBMET01793 0.216 0.013 DBMET01792 0.069 0.046 DBMET03120 | ||
| 0.369 | 0.005 | 0.383 | 5 Hydroxytryptamine 1A agonist | 0.229 0.008 DBMET01793 0.383 0.005 DBMET01792 0.298 0.006 DBMET03120 0.189 0.009 DBMET03121 | DBMET01792 | |
| 0.329 | 0.014 | 0.329 | 5 Hydroxytryptamine 2 antagonist | 0.253 0.021 DBMET01792 | ||
| 0.328 | 0.016 | 0.328 | 5 Hydroxytryptamine 1E antagonist | 0.183 0.15 DBMET01793 0.31 0.024 DBMET01792 | ||
| 0.27 | 0.013 | 0.27 | 5 Hydroxytryptamine 2A antagonist | 0.195 0.02 DBMET01792 | ||
| 0.282 | 0.052 | 0.419 | Interleukin antagonist | 0.251 0.061 DBMET01792 0.37 0.035 DBMET03120 0.419 0.028 DBMET03121 | DBMET03121 | |
| 0.297 | 0.09 | 0.297 | Vasodilator, coronary | 0.26 0.124 DBMET01792 | ||
| 0.211 | 0.007 | 0.211 | Prolactin inhibitor | 0.087 0.071 DBMET01793 0.123 0.036 DBMET01792 0.108 0.047 DBMET03120 0.128 0.033 DBMET03121 | ||
| 0.267 | 0.067 | 0.453 | Hypoglycemic | 0.169 0.149 DBMET01793 0.277 0.062 DBMET01792 0.396 0.028 DBMET03120 0.453 0.02 DBMET03121 | DBMET03121 | |
| 0.2 | 0.028 | 0.2 | Alpha adrenoreceptor antagonist | 0.142 0.04 DBMET01792 | ||
| 0.184 | 0.028 | 0.184 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.154 0.065 DBMET01793 0.176 0.036 DBMET01792 0.175 0.037 DBMET03120 0.169 0.044 DBMET03121 | ||
| 0.165 | 0.01 | 0.165 | Somatostatin 1 agonist | 0.141 0.016 DBMET01793 0.156 0.012 DBMET01792 0.152 0.013 DBMET03120 0.151 0.013 DBMET03121 | ||
| 0.231 | 0.082 | 0.231 | Vasodilator | 0.191 0.112 DBMET01792 0.198 0.106 DBMET03120 0.158 0.145 DBMET03121 | ||
| 0.146 | 0.005 | 0.146 | Neurokinin antagonist | 0.107 0.01 DBMET01793 0.107 0.01 DBMET01792 0.11 0.009 DBMET03120 0.076 0.018 DBMET03121 | ||
| 0.172 | 0.033 | 0.172 | 5 Hydroxytryptamine 2B antagonist | 0.108 0.074 DBMET01792 | ||
| 0.163 | 0.024 | 0.163 | Alpha 2 adrenoreceptor antagonist | 0.127 0.034 DBMET01792 | ||
| 0.143 | 0.005 | 0.153 | 5 Hydroxytryptamine 2A agonist | 0.153 0.005 DBMET01792 0.075 0.032 DBMET03120 0.06 0.046 DBMET03121 | DBMET01792 | |
| 0.21 | 0.076 | 0.213 | Anticonvulsant | 0.176 0.102 DBMET01792 0.161 0.116 DBMET03120 0.213 0.074 DBMET03121 | DBMET03121 | |
| 0.16 | 0.032 | 0.16 | Falcipain 3 inhibitor | 0.133 0.045 DBMET01792 0.091 0.08 DBMET03120 | ||
| 0.124 | 0.008 | 0.124 | Neurokinin 2 antagonist | 0.046 0.025 DBMET01793 0.085 0.013 DBMET01792 0.112 0.009 DBMET03120 0.068 0.017 DBMET03121 | ||
| 0.125 | 0.009 | 0.125 | Nicotinic receptor alpha7 subunit antagonist | 0.102 0.012 DBMET01792 0.064 0.025 DBMET03120 0.055 0.034 DBMET03121 | ||
| 0.145 | 0.036 | 0.174 | Nav1.4 sodium channel blocker | 0.114 0.058 DBMET01793 0.136 0.041 DBMET01792 0.134 0.042 DBMET03120 0.174 0.025 DBMET03121 | DBMET03121 | |
| 0.108 | 0.005 | 0.108 | Neurokinin 1 antagonist | 0.089 0.008 DBMET01793 0.081 0.009 DBMET01792 0.088 0.008 DBMET03120 0.054 0.017 DBMET03121 | ||
| 0.121 | 0.02 | 0.175 | 5 Hydroxytryptamine uptake inhibitor | 0.151 0.016 DBMET01793 0.175 0.013 DBMET01792 | DBMET01792 | |
| 0.175 | 0.076 | 0.221 | Lipocortins synthesis antagonist | 0.151 0.103 DBMET01793 0.166 0.085 DBMET01792 0.187 0.066 DBMET03120 0.221 0.045 DBMET03121 | DBMET03121 | |
| 0.122 | 0.028 | 0.122 | Histamine N-methyltransferase inhibitor | |||
| 0.126 | 0.034 | 0.126 | 5 Hydroxytryptamine 2C antagonist | 0.095 0.049 DBMET01792 | ||
| 0.105 | 0.014 | 0.105 | 5 Hydroxytryptamine 5A antagonist | 0.085 0.021 DBMET01792 | ||
| 0.102 | 0.015 | 0.102 | 5 Hydroxytryptamine 5 antagonist | 0.081 0.02 DBMET01792 | ||
| 0.101 | 0.014 | 0.101 | 5 Hydroxytryptamine 6 antagonist | 0.071 0.028 DBMET01792 | ||
| 0.132 | 0.049 | 0.132 | Alpha 2b adrenoreceptor antagonist | 0.103 0.072 DBMET01792 | ||
| 0.087 | 0.007 | 0.087 | Substance P antagonist | 0.074 0.008 DBMET01793 0.059 0.012 DBMET01792 0.052 0.015 DBMET03120 0.04 0.027 DBMET03121 | ||
| 0.091 | 0.011 | 0.091 | 5 Hydroxytryptamine 2 agonist | 0.082 0.014 DBMET01792 | ||
| 0.112 | 0.033 | 0.112 | Acetylcholine nicotinic antagonist | 0.092 0.044 DBMET01792 | ||
| 0.14 | 0.066 | 0.14 | Nav1.6 sodium channel blocker | |||
| 0.152 | 0.078 | 0.152 | Cyclin-dependent kinase 8 inhibitor | 0.131 0.101 DBMET01792 | ||
| 0.104 | 0.03 | 0.112 | Myeloperoxidase inhibitor | 0.112 0.024 DBMET01792 0.083 0.06 DBMET03120 | DBMET01792 | |
| 0.117 | 0.044 | 0.117 | Antihistaminic | 0.089 0.065 DBMET01792 | ||
| 0.111 | 0.04 | 0.111 | Alpha 1 adrenoreceptor antagonist | 0.084 0.051 DBMET01792 | ||
| 0.096 | 0.026 | 0.096 | Neuronal nicotinic receptor antagonist | 0.084 0.033 DBMET01792 | ||
| 0.111 | 0.042 | 0.111 | Histamine antagonist | 0.081 0.062 DBMET01792 | ||
| 0.073 | 0.01 | 0.079 | Somatostatin 1 antagonist | 0.062 0.014 DBMET01793 0.073 0.01 DBMET01792 0.079 0.009 DBMET03120 0.071 0.011 DBMET03121 | DBMET03120 | |
| 0.099 | 0.038 | 0.16 | Adrenaline agonist | 0.16 0.012 DBMET01792 0.114 0.028 DBMET03120 0.087 0.048 DBMET03121 | DBMET01792 | |
| 0.068 | 0.01 | 0.068 | Somatostatin agonist | 0.033 0.021 DBMET01793 0.054 0.012 DBMET01792 0.045 0.015 DBMET03120 0.04 0.017 DBMET03121 | ||
| 0.066 | 0.009 | 0.087 | Somatostatin 5 antagonist | 0.052 0.012 DBMET01793 0.07 0.009 DBMET01792 0.087 0.007 DBMET03120 0.08 0.008 DBMET03121 | DBMET03120 | |
| 0.057 | 0.005 | 0.057 | Urotensin II agonist | 0.032 0.013 DBMET01792 0.029 0.016 DBMET03121 | ||
| 0.063 | 0.011 | 0.063 | Somatostatin 4 agonist | 0.034 0.03 DBMET01793 0.048 0.016 DBMET01792 0.035 0.028 DBMET03120 0.033 0.032 DBMET03121 | ||
| 0.052 | 0.004 | 0.052 | 5 Hydroxytryptamine 6 agonist | 0.027 0.025 DBMET01792 | ||
| 0.061 | 0.015 | 0.061 | Leukotriene A4 hydrolase inhibitor | 0.041 0.025 DBMET01792 0.056 0.017 DBMET03120 0.05 0.02 DBMET03121 | ||
| 0.065 | 0.02 | 0.065 | Histamine H3 receptor antagonist | 0.052 0.025 DBMET01792 | ||
| 0.1 | 0.056 | 0.103 | Antiadrenergic | 0.103 0.054 DBMET01792 | DBMET01792 | |
| 0.058 | 0.015 | 0.058 | Oxytocin antagonist | 0.047 0.019 DBMET01792 0.043 0.022 DBMET03120 0.039 0.026 DBMET03121 | ||
| 0.059 | 0.016 | 0.065 | Growth hormone release inhibitor | 0.052 0.02 DBMET01793 0.063 0.015 DBMET01792 0.065 0.014 DBMET03120 0.06 0.016 DBMET03121 | DBMET03120 | |
| 0.097 | 0.055 | 0.099 | Adrenaline antagonist | 0.099 0.054 DBMET01792 | DBMET01792 | |
| 0.056 | 0.015 | 0.056 | GHS receptor agonist | 0.051 0.019 DBMET01792 0.05 0.02 DBMET03120 0.043 0.029 DBMET03121 | ||
| 0.053 | 0.014 | 0.063 | Somatostatin 2 antagonist | 0.035 0.019 DBMET01793 0.058 0.013 DBMET01792 0.063 0.011 DBMET03120 0.054 0.014 DBMET03121 | DBMET03120 | |
| 0.058 | 0.022 | 0.06 | Neurokinin 3 antagonist | 0.053 0.025 DBMET01792 0.06 0.02 DBMET03120 0.042 0.034 DBMET03121 | DBMET03120 | |
| 0.148 | 0.113 | 0.175 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.175 0.092 DBMET01792 | DBMET01792 | |
| 0.063 | 0.029 | 0.088 | NMDA 2B receptor antagonist | 0.054 0.037 DBMET01792 0.088 0.018 DBMET03120 | DBMET03120 | |
| 0.266 | 0.233 | 0.36 | Caspase 9 stimulant | 0.252 0.25 DBMET01792 0.36 0.137 DBMET03120 0.334 0.159 DBMET03121 | DBMET03120 | |
| 0.063 | 0.03 | 0.07 | Kallikrein 1 inhibitor | 0.055 0.042 DBMET01793 0.065 0.028 DBMET01792 0.064 0.029 DBMET03120 0.07 0.024 DBMET03121 | DBMET03121 | |
| 0.069 | 0.036 | 0.077 | Beta 3 adrenoreceptor antagonist | 0.077 0.026 DBMET01792 0.062 0.051 DBMET03120 | DBMET01792 | |
| 0.097 | 0.064 | 0.123 | Nitric-oxide synthase inhibitor | 0.123 0.036 DBMET01792 | DBMET01792 | |
| 0.044 | 0.011 | 0.052 | Melatonin receptor 1A agonist | 0.052 0.007 DBMET01792 0.032 0.027 DBMET03121 | DBMET01792 | |
| 0.087 | 0.054 | 0.099 | Factor XII inhibitor | 0.085 0.057 DBMET01792 0.091 0.048 DBMET03120 0.099 0.038 DBMET03121 | DBMET03121 | |
| 0.047 | 0.015 | 0.055 | Bombesin 1 receptor antagonist | 0.044 0.018 DBMET01793 0.055 0.01 DBMET01792 0.053 0.012 DBMET03120 0.042 0.02 DBMET03121 | DBMET01792 | |
| 0.046 | 0.014 | 0.05 | Somatostatin 5 agonist | 0.04 0.019 DBMET01793 0.05 0.012 DBMET01792 0.05 0.012 DBMET03120 0.048 0.014 DBMET03121 | DBMET03120 | |
| 0.05 | 0.019 | 0.107 | GABA B receptor antagonist | 0.04 0.036 DBMET01792 0.057 0.014 DBMET03120 0.107 0.005 DBMET03121 | DBMET03121 | |
| 0.182 | 0.151 | 0.23 | DNA synthesis inhibitor | 0.214 0.102 DBMET03120 0.23 0.083 DBMET03121 | DBMET03121 | |
| 0.076 | 0.045 | 0.078 | Macrophage colony-stimulating factor 1 receptor antagonist | 0.072 0.05 DBMET01792 0.078 0.043 DBMET03120 | DBMET03120 | |
| 0.092 | 0.064 | 0.092 | Alpha 2d adrenoreceptor antagonist | |||
| 0.051 | 0.024 | 0.065 | Cholecystokinin antagonist | 0.048 0.026 DBMET01792 0.041 0.029 DBMET03120 0.065 0.016 DBMET03121 | DBMET03121 | |
| 0.227 | 0.2 | 0.34 | Antibacterial | 0.254 0.173 DBMET01792 0.329 0.115 DBMET03120 0.34 0.108 DBMET03121 | DBMET03121 | |
| 0.129 | 0.104 | 0.159 | Adenylate cyclase stimulant | 0.159 0.049 DBMET01792 0.123 0.118 DBMET03121 | DBMET01792 | |
| 0.062 | 0.038 | 0.088 | Bombesin 1 receptor agonist | 0.056 0.046 DBMET01793 0.088 0.022 DBMET01792 0.067 0.034 DBMET03120 0.06 0.04 DBMET03121 | DBMET01792 | |
| 0.2 | 0.176 | 0.219 | Vasodilator, peripheral | 0.219 0.155 DBMET03120 0.211 0.164 DBMET03121 | DBMET03120 | |
| 0.061 | 0.038 | 0.066 | Gonadotropin-releasing hormone receptor agonist | 0.066 0.03 DBMET01793 | DBMET01793 | |
| 0.049 | 0.027 | 0.049 | Dopamine D2 agonist | |||
| 0.044 | 0.022 | 0.052 | Melanocortin 1 antagonist | 0.052 0.019 DBMET01792 0.035 0.029 DBMET03120 0.033 0.032 DBMET03121 | DBMET01792 | |
| 0.05 | 0.029 | 0.056 | Melanocortin antagonist | 0.056 0.024 DBMET01792 0.043 0.039 DBMET03120 | DBMET01792 | |
| 0.062 | 0.041 | 0.062 | CXC chemokine 4 receptor antagonist | 0.062 0.041 DBMET01792 | ||
| 0.032 | 0.012 | 0.032 | Motilin receptor antagonist | 0.028 0.019 DBMET01792 0.026 0.023 DBMET03120 | ||
| 0.028 | 0.01 | 0.036 | Elastase 2 inhibitor | 0.02 0.019 DBMET01793 0.026 0.012 DBMET01792 0.025 0.012 DBMET03120 0.036 0.007 DBMET03121 | DBMET03121 | |
| 0.028 | 0.01 | 0.036 | Elastase 2A inhibitor | 0.02 0.019 DBMET01793 0.026 0.012 DBMET01792 0.025 0.012 DBMET03120 0.036 0.007 DBMET03121 | DBMET03121 | |
| 0.026 | 0.01 | 0.035 | Somatostatin 3 antagonist | 0.02 0.014 DBMET01793 0.029 0.009 DBMET01792 0.035 0.008 DBMET03120 0.026 0.01 DBMET03121 | DBMET03120 | |
| 0.028 | 0.013 | 0.037 | Somatostatin 4 antagonist | 0.023 0.017 DBMET01793 0.031 0.011 DBMET01792 0.037 0.009 DBMET03120 0.028 0.013 DBMET03121 | DBMET03120 | |
| 0.071 | 0.057 | 0.071 | Alpha 2a adrenoreceptor antagonist | |||
| 0.035 | 0.021 | 0.041 | Growth hormone releasing factor agonist | 0.041 0.018 DBMET01792 | DBMET01792 | |
| 0.039 | 0.025 | 0.047 | Cholecystokinin A antagonist | 0.035 0.028 DBMET01792 0.047 0.021 DBMET03121 | DBMET03121 | |
| 0.042 | 0.029 | 0.051 | Melanocortin 4 antagonist | 0.051 0.023 DBMET01792 0.037 0.035 DBMET03120 0.037 0.035 DBMET03121 | DBMET01792 | |
| 0.066 | 0.053 | 0.066 | Alpha 1a adrenoreceptor antagonist | |||
| 0.071 | 0.059 | 0.071 | ErbB-4 antagonist | |||
| 0.115 | 0.103 | 0.158 | Neurotrophic factor | 0.158 0.052 DBMET03120 | DBMET03120 | |
| 0.021 | 0.01 | 0.028 | Follicle-stimulating hormone antagonist | 0.025 0.005 DBMET01792 0.028 0.005 DBMET03120 0.022 0.009 DBMET03121 | DBMET03120 | |
| 0.078 | 0.067 | 0.078 | Antineoplastic alkaloid | |||
| 0.027 | 0.016 | 0.027 | 5 Hydroxytryptamine 1F agonist | |||
| 0.269 | 0.258 | 0.315 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.315 0.193 DBMET01792 | DBMET01792 | |
| 0.039 | 0.028 | 0.043 | Histone deacetylase 9 inhibitor | 0.043 0.021 DBMET01792 | DBMET01792 | |
| 0.046 | 0.036 | 0.062 | Mineralocorticoid receptor antagonist | 0.048 0.034 DBMET01792 0.062 0.019 DBMET03120 0.057 0.023 DBMET03121 | DBMET03120 | |
| 0.062 | 0.052 | 0.082 | Beta adrenoreceptor antagonist | 0.082 0.025 DBMET01792 0.077 0.029 DBMET03120 | DBMET01792 | |
| 0.033 | 0.024 | 0.056 | Melatonin 1 agonist | 0.056 0.008 DBMET01792 | DBMET01792 | |
| 0.046 | 0.037 | 0.049 | Bombesin antagonist | 0.049 0.031 DBMET01792 0.049 0.031 DBMET03120 0.048 0.033 DBMET03121 | DBMET03120 | |
| 0.032 | 0.026 | 0.032 | Gonadotropin-releasing hormone receptor antagonist | |||
| 0.021 | 0.016 | 0.034 | Follicle-stimulating hormone agonist | 0.034 0.009 DBMET01792 0.022 0.016 DBMET03120 | DBMET01792 | |
| 0.019 | 0.013 | 0.019 | Somatostatin 3 agonist | 0.018 0.015 DBMET01792 | ||
| 0.052 | 0.047 | 0.052 | 5 Hydroxytryptamine 7 agonist | |||
| 0.028 | 0.024 | 0.037 | Cholecystokinin B antagonist | 0.037 0.016 DBMET03121 | DBMET03121 | |
| 0.033 | 0.03 | 0.041 | Histone deacetylase 7 inhibitor | 0.041 0.023 DBMET01792 | DBMET01792 | |
| 0.03 | 0.027 | 0.032 | GHS receptor antagonist | 0.032 0.022 DBMET01792 | DBMET01792 | |
| 0.097 | 0.094 | 0.123 | Acetylcholine release stimulant | 0.123 0.043 DBMET01792 | DBMET01792 | |
| 0.075 | 0.072 | 0.138 | NMDA receptor antagonist | 0.081 0.064 DBMET01792 0.105 0.044 DBMET03120 0.138 0.028 DBMET03121 | DBMET03121 | |
| 0.014 | 0.011 | 0.014 | Somatostatin 2 agonist | |||
| 0.075 | 0.073 | 0.075 | Acetylcholine agonist | |||
| 0.025 | 0.022 | 0.032 | Melanocortin 3 antagonist | 0.032 0.019 DBMET01792 | DBMET01792 | |
| 0.018 | 0.015 | 0.024 | Growth hormone release promoting | 0.024 0.012 DBMET01792 | DBMET01792 | |
| 0.03 | 0.027 | 0.054 | Melatonin agonist | 0.054 0.008 DBMET01792 | DBMET01792 | |
| 0.099 | 0.097 | 0.099 | Cholinergic antagonist | |||
| 0.033 | 0.033 | 0.039 | Cholecystokinin B agonist | 0.034 0.032 DBMET03120 0.039 0.025 DBMET03121 | DBMET03121 | |
| 0.034 | 0.034 | 0.044 | Histone deacetylase class I inhibitor | 0.044 0.023 DBMET01792 | DBMET01792 | |
| 0.025 | 0.025 | 0.032 | Factor VII inhibitor | 0.032 0.019 DBMET03121 | DBMET03121 | |
| 0.024 | 0.025 | 0.049 | Melatonin antagonist | 0.049 0.008 DBMET01792 | DBMET01792 | |
| 0.015 | 0.017 | 0.026 | Melatonin 3 antagonist | 0.026 0.01 DBMET01792 | DBMET01792 | |
| 0.057 | 0.06 | 0.062 | Histone deacetylase inhibitor | 0.062 0.051 DBMET01792 | DBMET01792 | |
| 0.027 | 0.033 | 0.064 | Melatonin 2 agonist | 0.064 0.007 DBMET01792 | DBMET01792 | |
| 0.05 | 0.058 | 0.076 | Alpha 2 adrenoreceptor agonist | 0.076 0.026 DBMET01792 | DBMET01792 | |
| 0.041 | 0.051 | 0.047 | Beta adrenoreceptor agonist | 0.047 0.024 DBMET01792 0.046 0.029 DBMET03120 0.043 0.042 DBMET03121 | DBMET01792 | |
| 0.056 | 0.073 | 0.062 | Beta 2 adrenoreceptor agonist | 0.062 0.04 DBMET01792 0.061 0.046 DBMET03120 | DBMET01792 | |
| 0.133 | 0.154 | 0.181 | Catenin beta inhibitor | 0.176 0.057 DBMET03120 0.181 0.051 DBMET03121 | DBMET03121 | |
| 0.107 | 0.13 | 0.168 | Anticoagulant | 0.128 0.102 DBMET03120 0.168 0.067 DBMET03121 | DBMET03121 | |
| 0.025 | 0.054 | 0.033 | Growth factor receptor-bound protein 2 antagonist | 0.033 0.028 DBMET03121 | DBMET03121 | |
| 0.048 | 0.079 | 0.08 | Alpha adrenoreceptor agonist | 0.08 0.038 DBMET01792 | DBMET01792 | |
| 0.009 | 0.043 | 0.02 | Melatonin 1 antagonist | 0.02 0.012 DBMET01792 | DBMET01792 | |
| 0.036 | 0.073 | 0.046 | Baculoviral IAP repeat-containing protein inhibitor | 0.046 0.033 DBMET01792 | DBMET01792 | |
| 0.045 | 0.083 | 0.064 | NMDA 2 receptor antagonist | 0.064 0.057 DBMET03120 | DBMET03120 | |
| 0.041 | 0.084 | 0.086 | Adrenaline uptake inhibitor | 0.083 0.025 DBMET01793 0.086 0.024 DBMET01792 | DBMET01792 | |
| 0.022 | 0.067 | 0.028 | Thiazolidinedione | 0.028 0.026 DBMET03120 | DBMET03120 | |
| 0.103 | 0.154 | 0.174 | Growth hormone agonist | 0.144 0.092 DBMET03120 0.174 0.071 DBMET03121 | DBMET03121 | |
| 0.03 | 0.081 | 0.051 | Beta 2 adrenoreceptor antagonist | 0.051 0.035 DBMET01792 | DBMET01792 | |
| 0.031 | 0.091 | 0.053 | Beta 1 adrenoreceptor antagonist | 0.053 0.043 DBMET01792 | DBMET01792 | |
| 0.117 | 0.179 | 0.168 | ATPase inhibitor | 0.168 0.073 DBMET03121 | DBMET03121 | |
| 0.031 | 0.101 | 0.059 | Neutrophil collagenase inhibitor | 0.059 0.052 DBMET03121 | DBMET03121 | |
| 0.055 | 0.126 | 0.09 | Inducible nitric-oxide synthase inhibitor | 0.09 0.048 DBMET01792 | DBMET01792 | |
| 0.008 | 0.081 | 0.022 | Thyroid hormone alpha agonist | 0.022 0.005 DBMET03121 | DBMET03121 | |
| 0.071 | 0.145 | 0.107 | Glutamate receptor antagonist | 0.107 0.089 DBMET03121 | DBMET03121 | |
| 0.028 | 0.106 | 0.052 | Alpha 1 adrenoreceptor agonist | 0.052 0.048 DBMET01792 | DBMET01792 | |
| 0.068 | 0.147 | 0.148 | Toll-Like receptor 3 antagonist | 0.148 0.015 DBMET01792 | DBMET01792 | |
| 0.029 | 0.112 | 0.062 | Glucagon-like peptide 1 agonist | 0.054 0.053 DBMET03120 0.062 0.046 DBMET03121 | DBMET03121 | |
| 0.052 | 0.136 | 0.073 | Chymotrypsin inhibitor | 0.073 0.064 DBMET03121 | DBMET03121 | |
| 0.059 | 0.149 | 0.294 | DNA intercalator | 0.294 0.012 DBMET01793 | DBMET01793 | |
| 0.106 | 0.196 | 0.213 | Insulin sensitizer | 0.154 0.127 DBMET03120 0.213 0.061 DBMET03121 | DBMET03121 | |
| 0.031 | 0.13 | 0.047 | Bombesin 2 receptor antagonist | 0.047 0.038 DBMET03121 | DBMET03121 | |
| 0.002 | 0.102 | 0.012 | Thyroid hormone beta agonist | 0.012 0.005 DBMET03121 | DBMET03121 | |
| 0.009 | 0.11 | 0.048 | GP IIb/IIIa receptor antagonist | 0.048 0.034 DBMET03121 | DBMET03121 | |
| 0.099 | 0.202 | 0.156 | Interleukin 6 antagonist | 0.156 0.081 DBMET03120 0.145 0.097 DBMET03121 | DBMET03120 | |
| 0.041 | 0.145 | 0.053 | Immunoglobulin Fc receptor antagonist | 0.053 0.046 DBMET01792 | DBMET01792 | |
| 0.012 | 0.124 | 0.046 | Thyroid hormone agonist | 0.046 0.005 DBMET03121 | DBMET03121 | |
| 0.042 | 0.161 | 0.058 | Histone deacetylase SIRT3 inhibitor | 0.058 0.056 DBMET01792 | DBMET01792 | |
| 0.005 | 0.126 | 0.03 | Prostaglandin EP3 antagonist | 0.03 0.021 DBMET03121 | DBMET03121 | |
| 0.062 | 0.184 | 0.098 | Microtubule formation inhibitor | 0.098 0.094 DBMET03121 | DBMET03121 | |
| 0.018 | 0.144 | 0.058 | NMDA 2C receptor antagonist | 0.058 0.048 DBMET03121 | DBMET03121 | |
| 0.028 | 0.156 | 0.072 | Phenylalanine 4-hydroxylase inhibitor | 0.064 0.053 DBMET03120 0.072 0.044 DBMET03121 | DBMET03121 | |
| 0.134 | 0.269 | 0.172 | Nitric-oxide synthase stimulant | 0.172 0.147 DBMET01792 | DBMET01792 | |
| 0.018 | 0.154 | 0.05 | Sphingosine 1-phosphate receptor agonist | 0.048 0.027 DBMET03120 0.05 0.025 DBMET03121 | DBMET03121 | |
| 0.05 | 0.189 | 0.131 | Triose-phosphate isomerase inhibitor | 0.12 0.033 DBMET03120 0.131 0.026 DBMET03121 | DBMET03121 | |
| 0.144 | 0.284 | 0.244 | Antiobesity | 0.244 0.162 DBMET03121 | DBMET03121 | |
| 0.012 | 0.152 | 0.042 | Sphingosine 1-phosphate receptor 1 agonist | 0.042 0.029 DBMET03120 0.041 0.031 DBMET03121 | DBMET03120 | |
| 0.009 | 0.154 | 0.054 | Free fatty acid receptor 1 antagonist | 0.034 0.023 DBMET03120 0.054 0.007 DBMET03121 | DBMET03121 | |
| 0.021 | 0.177 | 0.049 | Alpha-mannosidase inhibitor | 0.049 0.047 DBMET03120 | DBMET03120 | |
| 0.166 | 0.33 | 0.501 | Cyclophilin D inhibitor | 0.378 0.103 DBMET03120 0.501 0.05 DBMET03121 | DBMET03121 | |
| 0.125 | 0.294 | 0.267 | Antithrombotic | 0.267 0.113 DBMET03121 | DBMET03121 | |
| 0.082 | 0.265 | 0.265 | Platelet antagonist | 0.265 0.066 DBMET03121 | DBMET03121 | |
| 0.136 | 0.336 | 0.21 | Calcium channel activator | 0.21 0.199 DBMET01792 | DBMET01792 | |
| 0.064 | 0.263 | 0.189 | Phospholipase A2 inhibitor | 0.152 0.072 DBMET03120 0.189 0.049 DBMET03121 | DBMET03121 | |
| 0.042 | 0.245 | 0.083 | GABA B receptor agonist | 0.083 0.035 DBMET03121 | DBMET03121 | |
| 0.054 | 0.27 | 0.118 | Adenylate kinase inhibitor | 0.118 0.045 DBMET03121 | DBMET03121 | |
| 0.025 | 0.245 | 0.066 | Cathepsin G inhibitor | 0.066 0.059 DBMET03121 | DBMET03121 | |
| 0.015 | 0.238 | 0.098 | Peroxisome proliferator-activated receptor gamma agonist | 0.098 0.029 DBMET03121 | DBMET03121 | |
| 0.123 | 0.352 | 0.2 | Tyrosine 3 hydroxylase inhibitor | 0.2 0.135 DBMET03121 | DBMET03121 | |
| 0.101 | 0.356 | 0.205 | Immunomodulator | 0.205 0.158 DBMET03121 | DBMET03121 | |
| 0.052 | 0.313 | 0.127 | Interleukin 4 antagonist | 0.127 0.076 DBMET03121 | DBMET03121 | |
| 0.01 | 0.272 | 0.218 | Prostaglandin antagonist | 0.218 0.006 DBMET03121 | DBMET03121 | |
| 0.065 | 0.33 | 0.176 | Insulin secretagoues | 0.176 0.051 DBMET03121 | DBMET03121 | |
| 0.061 | 0.35 | 0.122 | Hemostatic | 0.122 0.109 DBMET03121 | DBMET03121 | |
| 0.005 | 0.296 | 0.051 | Kinesin antagonist | 0.051 0.016 DBMET01793 | DBMET01793 | |
| 0.005 | 0.296 | 0.051 | Kinesin-like protein 1 inhibitor | 0.051 0.016 DBMET01793 | DBMET01793 | |
| 0.085 | 0.378 | 0.232 | Gastrin inhibitor | 0.232 0.102 DBMET03121 | DBMET03121 | |
| 0.028 | 0.328 | 0.069 | Peroxisome proliferator-activated receptor gamma antagonist | 0.069 0.057 DBMET03121 | DBMET03121 | |
| 0.004 | 0.312 | 0.1 | Prostaglandin D2 antagonist | 0.1 0.005 DBMET03121 | DBMET03121 | |
| 0.096 | 0.415 | 0.235 | Histamine release inhibitor | 0.235 0.167 DBMET03121 | DBMET03121 | |
| 0.026 | 0.362 | 0.102 | GABA C receptor agonist | 0.102 0.064 DBMET03121 | DBMET03121 | |
| 0.034 | 0.42 | 0.121 | DOPA decarboxylase inhibitor | 0.121 0.044 DBMET03121 | DBMET03121 | |
| 0.028 | 0.417 | 0.086 | Bile acid receptor antagonist | 0.086 0.083 DBMET03121 | DBMET03121 | |
| 0.01 | 0.411 | 0.073 | Catalase inhibitor | 0.073 0.052 DBMET03121 | DBMET03121 | |
| 0.032 | 0.453 | 0.155 | Hypolipemic | 0.155 0.131 DBMET03121 | DBMET03121 | |
| 0.068 | 0.517 | 0.307 | Sodium/bile acid cotransporter inhibitor | 0.307 0.073 DBMET03121 | DBMET03121 | |
| 0.013 | 0.472 | 0.051 | Carnitine palmitoyltransferase 1B inhibitor | 0.051 0.028 DBMET03121 | DBMET03121 | |
| 0.068 | 0.679 | 0.266 | Interleukin 2 agonist | 0.266 0.102 DBMET03121 | DBMET03121 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |